|
市場調查報告書
心血管疾病的幹細胞研究：2009年
Stem Cells for Cardiovascular Disease 2009 Market Report
|
心血管疾病的幹細胞研究：2009年 是由出版商Select Biosciences, Ltd.在2009年01月所出版的。
這份英文市場調查報告書包含106 pages 價格從美金2510起跳。
本報告書內容包括：應用於心血管疾病的各種幹細胞分析、個別市場環境、定量市場動向、針對治療的醫療實驗動向等。內容綱要摘記如下：
第1章 該領域概要
- 本報告書的範圍
- 細胞治療領域的課題
- 心血管疾病的市場區隔
- 心血管疾病的市場機會
- 多細胞的ES細胞分化
第2章 應用於再生醫療的間質幹細胞（MSC）
- MSC：定義及特性
- MSC的表現型
- 心臟細胞系統的多樣化
- 周皮細胞：組織特有的前驅細胞
- MSC組織修復機制
- 胎兒的MSC及成人的MSC
第3章 應用於心血管疾病的幹細胞：技術概要、市場環境、醫療實驗動向
- 應用於心血管疾病的細胞治療
- 利用MSC的心血管修復機制
- 利用MSC的心血管疾病細胞治療提供管道
- 心血管疾病之幹細胞治療的安全性問題
- 心血管再生醫療領域的定量市場分析
- 應用於心血管疾病的幹細胞：醫療實驗動向
第4章 應用於心血管疾病的幹細胞：產業活動及進入企業
- 心血管疾病細胞治療領域的產業活動
- 心血管疾病細胞治療領域的企業介紹
附錄I：研究方法
附錄II：應用於心血管疾病的幹細胞：全球醫療實驗詳細資訊
附錄III：心血管疾病監查人口統計
Abstract
This is the latest and most up-to-date Worldwide Stem Cells Market Report from
Select Biosciences, based on our continual industry coverage. Select
Biosciences industry coverage in this report focuses on the technical, market,
and clinical trials aspects of stem cells being developed for addressing the
opportunities in the cardio and vascular disease spaces. Major emphasis is
placed on the various clinical applications of mesenchymal stem cells
(MSCs)ä€"a key stem cell lineage of paramount importance for
regenerative medicine. A Major Focus of this Report is on the Market Landscape
and Quantitative Market Trends in Cardiovascular Disease utilizing various
types of stem cell classes/lineages. Another key focus of this report is on
the various clinical trials either completed or in progress addressing
different therapeutic areas across the cardiovascular diseases landscape.
Extensive Worldwide Market Analyses Presented in this Report:
- Results and Analyses from Stem Cells-Focused Market Surveys Administered
to Large Respondent Pools of Industry Participants focused on Stem
Cellsä€ "Qualitative and Quantitative Market Trends are Analyzed and
Presented focusing on the cardiovascular disease spaces
- Breakout of the Market by Types of Stem Cells Utilized and Application
Areasä€ "in various therapeutic segments of the cardiovascular
disease therapeutics marketplace
- Quantitative Breakout of various types of stem cells in research and
clinical development for cardiovascular diseases
- Breakout of the Market by Therapeutic/Disease Segments
Addressedä€ "in the various segments of the cardiovascular disease
space
- Worldwide Stem Cells-focused Clinical Trials for Cardiovascular Diseases
- Qualitative and Quantitative Trends
- Sponsoring Institutions/Companies
- Types of Trials
- Types of Cells Utilized
- Clinical End-Points
- Progress Reports
- Competitive Landscape: Companies Focused on Developing Stem Cells-focused
Cellular Therapies for Different Disease Areas in the Cardiovascular
Spaceä€ "Qualitative and Quantitative Analyses
- Impact of Mesenchymal Stem Cells (MSCs) and other stem/progenitor cell
types for mediating cardiovascular disease regenerative medicine
- Mechanisms of action of MSCs in cardiovascular disease regenerative
medicine
- Delivery approaches for cellular therapy of cardiovascular diseases
Companies Profiled in This Market Report:
- Aastrom Biosciences
- Aldagen
- Angioblast Systems
- Arteriocyte
- Athersys
- Bioheart
- Cytori
- Geron
- Medistem
- Mytogen
- Osiris Therapeutics
- Pluristem
- t2cure
- TheraVitae
Table of Contents
Chapter 1. Executive Overview of the Space
- Scope of this Market Report
- Challenges in the Cellular Therapy Space
- Cardiovascular Disease Market Segmentation
- Cardiovascular Disease Market Opportunity
- Embryonic Stem Cell (ESC) Differentiation into Multiple Cellular
Chapter 2. Mesenchymal Stem Cells (MSCs) for Regenerative Medicine
- MSCs: Definition and Properties
- MSC Phenotype
- Heart Cell Lineage Diversification
- Pericytes: Tissue-Specific Progenitors
- Mechanisms of MSC-mediated Tissue Repair
- Fetal versus Adult MSCs
Chapter 3. Stem Cells for Cardiovascular Disease: Technology Landscape, Market Landscape, Clinical Trials Landscape
- Cellular Therapy for Cardiovascular Diseases
- Proposed Mechanisms of MSC-mediated Cardiovascular Repair
- Potential Delivery Routes of MSC-based Cellular Therapy for Cardiovascular
Diseases
- Safety Concerns with Stem Cell Therapy for Cardiovascular Disease
- Quantitative Market Analysis of the Cardiovascular Regenerative Medicine
Space
- Stem Cells for Cardiovascular Disease: Clinical Trials Landscape
Chapter 4. Stem Cells for Cardiovascular Disease: Selected Industry Events and Companies in the Space
- Selected Industry Events in Cardiovascular Cellular Therapy Sapce
- Profiles of Companies in the Cardiovascular Cellular Therapy Space
Appendix 1. Research Methodology
Appendix 2. Stem Cells for Cardiovascular Disease: Worldwide Clinical Trials Details
Appendix 3. Cardiovascular Disease Patient Population Statisstics
|
